CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +5,625 | $2.65 | $15K | 253,865 |
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −10,000 | 0 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −4,375 | 25,173 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −58,519 | 0 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −3,090 | 95,035 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −1,875 | 13,125 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −7,673 | 17,500 | ||
| 2020-04-01 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −5,625 | 7,500 | ||
| 2020-02-13 | Colangelo Dominick President and CEO | Option exercise | +10,313 | $1.95 | $20K | 183,104 |
| 2020-02-13 | Colangelo Dominick President and CEO | Option exercise | +13,125 | $2.75 | $36K | 196,229 |
| 2020-02-13 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −10,313 | 53,183 | ||
| 2020-02-13 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −13,125 | 78,750 | ||
| 2020-02-11 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +219,445 | 219,445 | ||
| 2020-02-11 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +30,000 | 30,000 | ||
| 2020-02-11 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +5,555 | 5,555 | ||
| 2020-02-11 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +6,500 | 6,500 | ||
| 2020-02-11 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +7,098 | 7,098 | ||
| 2020-02-11 | Hopper Jonathan Mark Chief Medical Officer | Grant or award · Stock Option (right to buy) | +41,652 | 41,652 | ||
| 2020-02-11 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +98,301 | 98,301 | ||
| 2020-02-11 | Halpin Michael Chief Operating Officer | Grant or award · Restricted Stock Unit | +14,000 | 14,000 |
Page 56 of 75 · 1,497 trades